Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...
According to the National Capital Poison Center, a not-for-profit poison control organization, at least 85 drugs—including ...
If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...